Hadrien Mallet
YOU?
Author Swipe
View article: Effectiveness of complement inhibitors against refractory antibody-mediated rejection of lung transplantation: Two clinical cases
Effectiveness of complement inhibitors against refractory antibody-mediated rejection of lung transplantation: Two clinical cases Open
Antibody-mediated rejection (AMR) has been recognized as a significant cause of acute and chronic lung allograft dysfunction after lung transplantation. Some treatments, eculizumab, an anti-complement (C)5 component monoclonal antibody (Ma…